The Surgical Hemostat Market Comparison and New Hemostat Technology Blog
Friday, July 18, 2008
Baxter Q2 - Strong Floseal and Coseal results
Rob Davis said "Sales of regenerative medicine business totaled $109 million and increased 25%, with currency contributing 8 percentage points of growth. This continues to be the result of strong growth of FLOSEAL and COSEAL." Full transcript HERE
No comments:
Post a Comment